With respect to RAC1B, in vitro and in vivo experiments revealed that RAC1B deletion in colorectal cancer decreased EGFR phosphorylation and downstream pathway activation, suggesting RAC1B plays a significant role in EGFR signaling [94]. This evidence concerns the gene EGFR and colorectal cancer.